Semi-Annual Consolidated Statement Of Cash Flows

Kidswell Bio Corporation - Filing #7297119

Concept As at
2024-09-30
2024-04-01 to
2024-09-30
As at
2024-03-31
Semi-annual consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
-240,894,000 JPY
Depreciation
450,000 JPY
Interest expenses
21,141,000 JPY
Decrease (increase) in trade receivables
373,563,000 JPY
Decrease (increase) in inventories
122,955,000 JPY
Increase (decrease) in trade payables
-27,896,000 JPY
Other, net
63,110,000 JPY
Subtotal
-258,089,000 JPY
Interest paid
-28,934,000 JPY
Income taxes paid
-1,525,000 JPY
Net cash provided by (used in) operating activities
-288,426,000 JPY
Cash flows from investing activities
Net cash provided by (used in) investing activities
-2,954,000 JPY
Cash flows from financing activities
Repayments of long-term borrowings
-443,520,000 JPY
Net cash provided by (used in) financing activities
-244,657,000 JPY
Net increase (decrease) in cash and cash equivalents
-536,038,000 JPY
Cash and cash equivalents
1,695,373,000 JPY
2,231,411,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.